2Z)-2-Cyano-3-cyclopropyl-3-hydroxy-N-[3-methyl-4-(trifluoromethyl)phenyl]-2-propenamide Sodium Salt; |(Z)-2-Cyano-3-cyclopropyl-3-hydroxy-N-[3-methyl-4-(trifluoromethyl)phenyl]-2-propenamide; (Z)-α-Cyano-α4',α4',α4'-trifluoro-β-hydroxycyclopropaneacrylo-3',4'-xylidide Sodium Salt
Laflunimus Sodium Salt, is used to treat neuropathic pain and the neuropathic pain syndromes.
Synonyms
2Z)-2-Cyano-3-cyclopropyl-3-hydroxy-N-[3-methyl-4-(trifluoromethyl)phenyl]-2-propenamide Sodium Salt; (Z)-2-Cyano-3-cyclopropyl-3-hydroxy-N-[3-methyl-4-(trifluoromethyl)phenyl]-2-propenamide; (Z)-α-Cyano-α4',α4',α4'-trifluoro-β-hydroxycyclopropaneacrylo-3',4'-xylidide Sodium Salt
CAS No
147076-36-6 Free Acid: 147076-36-6
Molecular Formula
C15H12F3N2NaO2
Appearance
Off-white to pale beige solid
Solubility
Methanol (Slightly), Ethyl Acetate (Slightly)
Elemental Analysis
Calculated: %C: 54.22, %H: 3.64, %N: 8.43
Sodium
~7% (by Ion Chromatography)
Storage and Stability
Store at -20°C under inert atmosphere. Stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Toxicity and Hazards
All products should be handled by qualified personnel only, trained in laboratory procedures.